Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Anal Canal Carcinoma × Proctoscopy × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Anus Neoplasms 1 Anal Canal Carcinoma 1

Interventions

Radiotherapy 3 Fluorouracil 3 Cisplatin 3 Mitomycin 2 X-Rays 1 Watchful Waiting 1 Specimen Handling 1 Sigmoidoscopy 1 Radiation 1 Proctoscopy 1 Phantoms, Imaging 1 Observation 1 Nivolumab 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Immune Checkpoint Inhibitors 1 Colonoscopy 1 Chemoradiotherapy 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03233711 2026-03-18

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡